entered into a letter of intent with VERDI Solutions GmbH to develop personalized and off-the-shelf peptide vaccines for cancer patients. VERDI Solutions, headquartered in Vienna, Austria ...
VERDI Solutions, headquartered in Vienna, Austria, is developing personalized ... which their oncologists administered under Heilversuch. Under the letter of intent, VERDI has granted Anixa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback